SCHEDULE: Strata Critical Medical Ownership Update

Steele ExpCo Holdings, LLC, KSL Capital Partners V GP, LLC, and Eric Charles Resnick have updated their beneficial ownership filing for Strata Critical Medical, Inc., reporting 9.0% ownership.

Summary

• This filing is an amendment (Amendment No. 3) to a Schedule 13G, updating the beneficial ownership information for Strata Critical Medical, Inc.
• The reporting persons are Steele ExpCo Holdings, LLC, KSL Capital Partners V GP, LLC, and Eric Charles Resnick.
• Collectively, they beneficially own 7,923,000 shares of Class A Common Stock, representing 9.0% of the outstanding shares.
• This ownership percentage is based on 88,466,806 shares of Class A Common Stock outstanding as of July 28, 2026.
• Steele ExpCo Holdings, LLC directly holds the shares, KSL Capital Partners V GP, LLC is its managing member, and Eric Charles Resnick is the managing member of KSL Capital Partners V GP, LLC.
• 4,500,000 warrants held by Steele ExpCo Holding, LLC expired on May 7, 2026.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing, primarily an update on beneficial ownership, with no new strategic or financial performance information.

Positives

• Reporting persons maintain a significant stake (9.0%) in Strata Critical Medical, Inc., indicating continued investor interest.
• The filing clarifies the ownership structure and reporting relationships among the entities and individuals involved.

Negatives

• The expiration of 4,500,000 warrants represents a reduction in potential future share count controlled by the reporting persons.

Risks

• The filing does not introduce new risks but is an update to existing ownership disclosures.
• Potential future changes in beneficial ownership could impact the company's stock.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding the company's future performance. It is solely an update to beneficial ownership.

Management Comments

• "As of the date hereof, the Reporting Persons beneficially own an aggregate of 7,923,000 shares of Class A Common Stock held by Steele ExpCo Holding, LLC, representing approximately 9.0% of the Class A Common Stock, calculated pursuant to Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the "Exchange Act")."
• "KSL Capital Partners V GP, LLC, a Delaware limited liability company, is the managing member of Steele ExpCo Holdings, LLC. Eric Charles Resnick is the managing member of KSL Capital Partners V GP, LLC. As such, KSL Capital Partners V GP, LLC and Eric Charles Resnick may be deemed to have or share voting and dispositive power of the securities held directly by Steele ExpCo Holdings, LLC."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine for institutional investors and significant shareholders, indicating changes or confirmations in ownership stakes. This filing does not reflect operational performance but rather the investment positions of specific entities.

Stakeholder Impact

• Shareholders: The filing confirms the ownership stake of key entities, providing transparency on who holds a significant portion of the company's stock.
• Management: The filing clarifies the reporting structure and control over the beneficial ownership.

Next Steps

• Reporting persons will continue to file amendments to Schedule 13G as required by SEC regulations for any material changes in beneficial ownership.

Key Dates

Keywords

Strata Critical Medical, Schedule 13G, Beneficial Ownership, Steele ExpCo Holdings, KSL Capital Partners, Eric Charles Resnick, Class A Common Stock, Warrants